Wiiliam A. Boeger

Fondatore presso Chronix Biomedical, Inc.

Consumer Services

Health Technology

Profilo

Wiiliam A.
Boeger is the founder who starts Chronix Biomedical, Inc. in 1997, where he currently serves as Director & Director-Business Development.
He was previously Chairman & Chief Executive Officer at Calypte Biomedical Corp.
and held positions as Faculty at Dartmouth College and Principal at Harvard Medical School.
Boeger holds an MBA from Harvard University and an undergraduate degree from Williams College.

Posizioni attive di Wiiliam A. Boeger

Società	Posizione	Inizio
Chronix Biomedical, Inc. Chronix Biomedical, Inc. Medical SpecialtiesHealth Technology Chronix Biomedical, Inc. manufactures diagnostic substances chemicals. It develops DNA-based blood tests primarily for monitoring minimal residual disease in cancer patients. The firm also develops a technology that measures personalized biomarkers in cancers of the colorectum, prostate, lung, ovarian, pancreas, blood and central nervous system. The company was founded by Wiiliam A. Boeger and Howard B. Urnovitz in 1997 and is headquartered in San Jose, CA.	Fondatore	01/01/1997

Tutte le posizioni attive di Wiiliam A. Boeger

Precedenti posizioni note di Wiiliam A. Boeger

Società	Posizione	Fine
Harvard Medical School	Corporate Officer/Principal	-
Dartmouth College	Corporate Officer/Principal	-
CALYPTE BIOMEDICAL CORPORATION	Presidente	-

Vedi nel dettaglio l'esperienza di Wiiliam A. Boeger

Formazione di Wiiliam A. Boeger

Williams College	Undergraduate Degree
Harvard University	Masters Business Admin

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Wiiliam A. Boeger

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	2
Chronix Biomedical, Inc. Chronix Biomedical, Inc. Medical SpecialtiesHealth Technology Chronix Biomedical, Inc. manufactures diagnostic substances chemicals. It develops DNA-based blood tests primarily for monitoring minimal residual disease in cancer patients. The firm also develops a technology that measures personalized biomarkers in cancers of the colorectum, prostate, lung, ovarian, pancreas, blood and central nervous system. The company was founded by Wiiliam A. Boeger and Howard B. Urnovitz in 1997 and is headquartered in San Jose, CA.	Health Technology
Calypte Biomedical Corp. Calypte Biomedical Corp. Medical SpecialtiesHealth Technology Calypte Biomedical Corp. develops, manufactures and distributes vitro testing products, which improves the diagnosis of Human Immunodeficiency Virus infection, sexually transmitted diseases and other chronic diseases. The company's product line includes both point-of-case rapid tests and the BED incidence test. Calypte Biomedical was founded in 1988 and is headquartered in Portland, OR.	Health Technology